Sfoglia per Autore
Predictive role of haemoglobin on disease response to neoadjuvant chemotherapy in breast cancer.
2016 Omarini, Claudia; Iattoni, Elena; Filieri, Maria Elisabetta; Toss, Angela; Grizzi, Giulia; DEL GIOVANE, Cinzia; Valentina Tamma, Antonella; Cascinu, Stefano; Piacentini, Federico
Clinical-pathological features and treatment modalities associated with recurrence in DCIS and micro-invasive carcinoma: Who to treat more and who to treat less
2016 Toss, A.; Palazzo, J.; Berger, A.; Guiles, F.; Sendecki, J. A.; Simone, N.; Anne, R.; Avery, T.; Jaslow, R.; Lazar, M.; Tsangaris, T.; Cristofanilli, M.
The impact of reproductive life on breast cancer risk in women with family history or BRCA mutation
2017 Toss, A.; Grandi, G.; Cagnacci, A.; Marcheselli, L.; Pavesi, S.; De Matteis, E.; Razzaboni, E.; Tomasello, C.; Cascinu, S.; Cortesi, L.
Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores
2017 Lecarpentier, J.; Kuchenbaecker, K. B.; Barrowdale, D.; Dennis, J.; McGuffog, L.; Leslie, G.; Lee, A.; Al Olama, A. A.; Tyrer, J. P.; Frost, D.; Ellis, S.; Easton, D. F.; Antoniou, A. C.; Tischkowitz, M.; Evans, D. G.; Henderson, A.; Brewer, C.; Eccles, D.; Cook, J.; Ong, K. -R.; Walker, L.; Side, L. E.; Hodgson, S.; Izatt, L.; Eeles, R.; Orr, N.; Porteous, M. E.; Davidson, R.; Adlard, J.; Silvestri, V.; Rizzolo, P.; Navazio, A. S.; Valentini, V.; Zelli, V.; Ottini, L.; Toss, A.; Medici, V.; Cortesi, L.; Zanna, I.; Palli, D.; Radice, P.; Manoukian, S.; Peissel, B.; Azzollini, J.; Peterlongo, P.; Viel, A.; Cini, G.; Damante, G.; Tommasi, S.; Alducci, E.; Tognazzo, S.; Montagna, M.; Caligo, M. A.; Soucy, P.; Simard, J.; Mulligan, A. M.; Andrulis, I. L.; Glendon, G.; Southey, M.; Campbell, I.; James, P.; Mitchell, G.; Spurdle, A. B.; Holland, H.; Chenevix-Trench, G.; John, E. M.; Steele, L.; Ding, Y. C.; Neuhausen, S. L.; Weitzel, J. N.; Conner, T. A.; Buys, S. S.; Goldgar, D. E.; Godwin, A. K.; Sharma, P.; Rebbeck, T. R.; Vijai, J.; Robson, M.; Lincoln, A.; Musinsky, J.; Gaddam, P.; Offit, K.; Loud, J. T.; Greene, M. H.; Toland, A. E.; Senter, L.; Huo, D.; Nielsen, S. M.; Olopade, O. I.; Nathanson, K. L.; Domchek, S. M.; Lorenchick, C.; Jankowitz, R. C.; Couch, F. J.; Janavicius, R.; Hansen, T. V. O.; Bojesen, A.; Nielsen, H. R.; Skytte, A. -B.; Sunde, L.; Jensen, U. B.; Pedersen, I. S.; Krogh, L.; Kruse, T. A.; Thomassen, M.; Osorio, A.; De La Hoya, M.; Garcia-Barberan, V.; Caldes, T.; Segura, P. P.; Balmana, J.; Gutierrez-Enriquez, S.; Diez, O.; Teule, A.; Del Valle, J.; Feliubadalo, L.; Pujana, M. A.; Lazaro, C.; Izquierdo, A.; Darder, E.; Brunet, J.; Fostira, F.; Hamann, U.; Sutter, C.; Meindl, A.; Ditsch, N.; Gehrig, A.; Dworniczak, B.; Engel, C.; Wand, D.; Niederacher, D.; Steinemann, D.; Hahnen, E.; Hauke, J.; Rhiem, K.; Wappenschmidt, B.; Schmutzler, R. K.; Kast, K.; Arnold, N.; Wang-Gohrke, S.; Lasset, C.; Damiola, F.; Barjhoux, L.; Mazoyer, S.; Stoppa-Lyonnet, D.; Belotti, M.; Van Heetvelde, M.; Poppe, B.; De Leeneer, K.; Claes, K. B. M.; Kiiski, J. I.; Khan, S.; Nevanlinna, H.; Aittomaki, K.; Vvan Asperen, C. J.; Vaszko, T.; Kasler, M.; Olah, E.; Arason, A.; Agnarsson, B. A.; Johannsson, O. Th.; Barkardottir, R. B.; Teixeira, M. R.; Pinto, P.; Lee, J. W.; Lee, M. H.; Lee, J.; Kim, S. -W.; Kang, E.; Park, S. K.; Kim, Z.; Tan, Y. Y.; Berger, A.; Singer, C. F.; Yoon, S. -Y.; Teo, S. -H.; Von Wachenfeldt, A.
Fertility and pregnancy issues in BRCA-mutated breast cancer patients
2017 Lambertini, M.; Goldrat, O.; Toss, A.; Azim, H. A.; Peccatori, F. A.; Ignatiadis, M.; Del Mastro, L.; Demeestere, I.
Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort Study
2017 Cortesi, Laura; De Matteis, Elisabetta; Toss, Angela; Marchi, Isabella; Medici, Veronica; Contu, Giannina; Xholli, Anjeza; Grandi, Giovanni; Cagnacci, Angelo; Federico, Massimo
Molecular Biomarkers for Prediction of Targeted Therapy Response in Metastatic Breast Cancer: Trick or Treat?
2017 Toss, Angela; Venturelli, Marta; Peterle, Chiara; Piacentini, Federico; Cascinu, Stefano; Cortesi, Laura
First-line treatment for endocrine sensitive bone-only metastatic breast cancer: Is more always better?
2018 Toss, A; Venturelli, M; Sperduti, I; Isca, C; Molinaro, E; Barbieri, E; Piacentini, F; Omarini, C; Cortesi, L; Cascinu, S; Moscetti,
ERBB2 mutations in hormone receptor positive primary breast cancers samples and in their matched endocrine-resistant recurrences.
2018 Venturelli, M.; Toss, A.; Piacentini, F.; Artuso, L.; Bernardis, I.; Parenti, S.; Tenedini, E.; Omarini, C.; Moscetti., 1; Cascinu, S.; Tagliafico, E.; Cortesi, L.
Cancer Treatment Induced Bone Loss (CTIBL) in breast cancer women: a multidisciplinary approach at the Modena Cancer Center screening over 600 patients.
2018 Pozzi, S.; Belletti, L.; Cortesi, L.; Moscetti, L.; Omarini, C.; Piacentini, F.; Toss, A.; Caputo, Francesco; Greco, S.; Isca, C.; Napolitano, M.; Tarantino, V.; Malinverni, C.; Checchi, Eleonora; Mascia, Maria Teresa; Cascinu, S
Endocrine sensitive metastatic breast cancer and bone only disease: are the new treatments always better?
2018 Toss, A.; Venturelli, M.; Sperduti, I.; Isca, C.; Barbieri, E.; Piacentini, F.; Omarini, C.; Cortesi, L; Cascinu, Stefano; Moscetti, L.
Primary and secondary prevention to effectively reduce the risk of bisphosphonate-related osteonecrosis of the jaw in patients with bone metastases .
2018 Piacentini, F; Omarini, C; Garuti, G; Badea, M; Moscetti, L; Cortesi, L; Toss, A; Barbieri, E; Barbolini, M; Guaitoli, G; Caputo, F; Cascinu, S
Combined Hormonal Contraceptive Use and Risk of Breast Cancer in a Population of Women With a Family History
2018 Grandi, Giovanni; Toss, Angela; Cagnacci, Angelo; Marcheselli, Luigi; Pavesi, Silvia; Facchinetti, Fabio; Cascinu, Stefano; Cortesi, Laura
Genomic alterations at the basis of treatment resistance in metastatic breast cancer: Clinical applications
2018 Toss, Angela; Piacentini, Federico; Cortesi, Laura; Artuso, Lucia; Bernardis, Isabella; Parenti, Sandra; Tenedini, Elena; Ficarra, Guido; Maiorana, Antonino; Iannone, Anna; Omarini, Claudia; Moscetti, Luca; Cristofanilli, Massimo; Federico, Massimo; Tagliafico, Enrico
Clinical and molecular predictors of long-term response in HER2 positive metastatic breast cancer patients.
2018 Omarini, C; Bettelli, S; Caprera, C; Manfredini, S; Caggia, F; Guaitoli, G; Moscetti, L; Toss, A; Cortesi, L; Kaleci, S; Maiorana, A; Cascinu, S; Conte, Pf; Piacentini, F
PARP inhibitors for the treatment of ovarian cancer
2018 Cortesi, Lisa; Toss, A.; Cucinotto, I.
First-line treatment for endocrine sensitive bone-only metastatic breast cancer: Is more always better?
2018 Toss, A.; Venturelli, Marta; Sperduti, I.; Isca, Chrystel; Barbieri, Elena; Piacentini, F.; Omarini, C.; Cortesi, L.; Cascinu, S.; Moscetti, L.
Clinical-Pathological Characteristics of HER2+ Breast Cancers patients among BRCA1/2+ carriers tested in Modena Cancer Center.
2019 Barbolini, M; Omarini, C; Viola, L; Isca, C; Marchi, I; Caggia, F; Barbieri, E; Toss, A; Cortesi, L; Dominici, M; Piacentini, F.
Endocrine therapy alone versus targeted combination strategy as first line treatment in elderly patients with hormone receptor-positive advanced breast cancer: Meta-analysis of phase II and III randomized clinical trial
2019 Omarini, C; Sperduti, I; Barbolini, M; Isca, C; Bocconi, Alessandro; Toss, A; Cortesi, L; Barbieri, E; Piacentini, F; Cascinu, S; Moscetti, L
BRCA mutations among triple negative breast cancer without family history of breast and ovarian cancer: The Modena family cancer clinic experience
2019 Molinaro, E.; Venturelli, M.; Toss, A.; Piombino, C.; Barbieri, E.; Marcheselli, L.; Marchi, I.; Tagliafico, E.; Cascinu, S.; Cortesi, L.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Predictive role of haemoglobin on disease response to neoadjuvant chemotherapy in breast cancer. | 1-gen-2016 | Omarini, Claudia; Iattoni, Elena; Filieri, Maria Elisabetta; Toss, Angela; Grizzi, Giulia; DEL GIOVANE, Cinzia; Valentina Tamma, Antonella; Cascinu, Stefano; Piacentini, Federico | |
| Clinical-pathological features and treatment modalities associated with recurrence in DCIS and micro-invasive carcinoma: Who to treat more and who to treat less | 1-gen-2016 | Toss, A.; Palazzo, J.; Berger, A.; Guiles, F.; Sendecki, J. A.; Simone, N.; Anne, R.; Avery, T.; Jaslow, R.; Lazar, M.; Tsangaris, T.; Cristofanilli, M. | |
| The impact of reproductive life on breast cancer risk in women with family history or BRCA mutation | 1-gen-2017 | Toss, A.; Grandi, G.; Cagnacci, A.; Marcheselli, L.; Pavesi, S.; De Matteis, E.; Razzaboni, E.; Tomasello, C.; Cascinu, S.; Cortesi, L. | |
| Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores | 1-gen-2017 | Lecarpentier, J.; Kuchenbaecker, K. B.; Barrowdale, D.; Dennis, J.; McGuffog, L.; Leslie, G.; Lee, A.; Al Olama, A. A.; Tyrer, J. P.; Frost, D.; Ellis, S.; Easton, D. F.; Antoniou, A. C.; Tischkowitz, M.; Evans, D. G.; Henderson, A.; Brewer, C.; Eccles, D.; Cook, J.; Ong, K. -R.; Walker, L.; Side, L. E.; Hodgson, S.; Izatt, L.; Eeles, R.; Orr, N.; Porteous, M. E.; Davidson, R.; Adlard, J.; Silvestri, V.; Rizzolo, P.; Navazio, A. S.; Valentini, V.; Zelli, V.; Ottini, L.; Toss, A.; Medici, V.; Cortesi, L.; Zanna, I.; Palli, D.; Radice, P.; Manoukian, S.; Peissel, B.; Azzollini, J.; Peterlongo, P.; Viel, A.; Cini, G.; Damante, G.; Tommasi, S.; Alducci, E.; Tognazzo, S.; Montagna, M.; Caligo, M. A.; Soucy, P.; Simard, J.; Mulligan, A. M.; Andrulis, I. L.; Glendon, G.; Southey, M.; Campbell, I.; James, P.; Mitchell, G.; Spurdle, A. B.; Holland, H.; Chenevix-Trench, G.; John, E. M.; Steele, L.; Ding, Y. C.; Neuhausen, S. L.; Weitzel, J. N.; Conner, T. A.; Buys, S. S.; Goldgar, D. E.; Godwin, A. K.; Sharma, P.; Rebbeck, T. R.; Vijai, J.; Robson, M.; Lincoln, A.; Musinsky, J.; Gaddam, P.; Offit, K.; Loud, J. T.; Greene, M. H.; Toland, A. E.; Senter, L.; Huo, D.; Nielsen, S. M.; Olopade, O. I.; Nathanson, K. L.; Domchek, S. M.; Lorenchick, C.; Jankowitz, R. C.; Couch, F. J.; Janavicius, R.; Hansen, T. V. O.; Bojesen, A.; Nielsen, H. R.; Skytte, A. -B.; Sunde, L.; Jensen, U. B.; Pedersen, I. S.; Krogh, L.; Kruse, T. A.; Thomassen, M.; Osorio, A.; De La Hoya, M.; Garcia-Barberan, V.; Caldes, T.; Segura, P. P.; Balmana, J.; Gutierrez-Enriquez, S.; Diez, O.; Teule, A.; Del Valle, J.; Feliubadalo, L.; Pujana, M. A.; Lazaro, C.; Izquierdo, A.; Darder, E.; Brunet, J.; Fostira, F.; Hamann, U.; Sutter, C.; Meindl, A.; Ditsch, N.; Gehrig, A.; Dworniczak, B.; Engel, C.; Wand, D.; Niederacher, D.; Steinemann, D.; Hahnen, E.; Hauke, J.; Rhiem, K.; Wappenschmidt, B.; Schmutzler, R. K.; Kast, K.; Arnold, N.; Wang-Gohrke, S.; Lasset, C.; Damiola, F.; Barjhoux, L.; Mazoyer, S.; Stoppa-Lyonnet, D.; Belotti, M.; Van Heetvelde, M.; Poppe, B.; De Leeneer, K.; Claes, K. B. M.; Kiiski, J. I.; Khan, S.; Nevanlinna, H.; Aittomaki, K.; Vvan Asperen, C. J.; Vaszko, T.; Kasler, M.; Olah, E.; Arason, A.; Agnarsson, B. A.; Johannsson, O. Th.; Barkardottir, R. B.; Teixeira, M. R.; Pinto, P.; Lee, J. W.; Lee, M. H.; Lee, J.; Kim, S. -W.; Kang, E.; Park, S. K.; Kim, Z.; Tan, Y. Y.; Berger, A.; Singer, C. F.; Yoon, S. -Y.; Teo, S. -H.; Von Wachenfeldt, A. | |
| Fertility and pregnancy issues in BRCA-mutated breast cancer patients | 1-gen-2017 | Lambertini, M.; Goldrat, O.; Toss, A.; Azim, H. A.; Peccatori, F. A.; Ignatiadis, M.; Del Mastro, L.; Demeestere, I. | |
| Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort Study | 1-gen-2017 | Cortesi, Laura; De Matteis, Elisabetta; Toss, Angela; Marchi, Isabella; Medici, Veronica; Contu, Giannina; Xholli, Anjeza; Grandi, Giovanni; Cagnacci, Angelo; Federico, Massimo | |
| Molecular Biomarkers for Prediction of Targeted Therapy Response in Metastatic Breast Cancer: Trick or Treat? | 1-gen-2017 | Toss, Angela; Venturelli, Marta; Peterle, Chiara; Piacentini, Federico; Cascinu, Stefano; Cortesi, Laura | |
| First-line treatment for endocrine sensitive bone-only metastatic breast cancer: Is more always better? | 1-gen-2018 | Toss, A; Venturelli, M; Sperduti, I; Isca, C; Molinaro, E; Barbieri, E; Piacentini, F; Omarini, C; Cortesi, L; Cascinu, S; Moscetti, | |
| ERBB2 mutations in hormone receptor positive primary breast cancers samples and in their matched endocrine-resistant recurrences. | 1-gen-2018 | Venturelli, M.; Toss, A.; Piacentini, F.; Artuso, L.; Bernardis, I.; Parenti, S.; Tenedini, E.; Omarini, C.; Moscetti., 1; Cascinu, S.; Tagliafico, E.; Cortesi, L. | |
| Cancer Treatment Induced Bone Loss (CTIBL) in breast cancer women: a multidisciplinary approach at the Modena Cancer Center screening over 600 patients. | 1-gen-2018 | Pozzi, S.; Belletti, L.; Cortesi, L.; Moscetti, L.; Omarini, C.; Piacentini, F.; Toss, A.; Caputo, Francesco; Greco, S.; Isca, C.; Napolitano, M.; Tarantino, V.; Malinverni, C.; Checchi, Eleonora; Mascia, Maria Teresa; Cascinu, S | |
| Endocrine sensitive metastatic breast cancer and bone only disease: are the new treatments always better? | 1-gen-2018 | Toss, A.; Venturelli, M.; Sperduti, I.; Isca, C.; Barbieri, E.; Piacentini, F.; Omarini, C.; Cortesi, L; Cascinu, Stefano; Moscetti, L. | |
| Primary and secondary prevention to effectively reduce the risk of bisphosphonate-related osteonecrosis of the jaw in patients with bone metastases . | 1-gen-2018 | Piacentini, F; Omarini, C; Garuti, G; Badea, M; Moscetti, L; Cortesi, L; Toss, A; Barbieri, E; Barbolini, M; Guaitoli, G; Caputo, F; Cascinu, S | |
| Combined Hormonal Contraceptive Use and Risk of Breast Cancer in a Population of Women With a Family History | 1-gen-2018 | Grandi, Giovanni; Toss, Angela; Cagnacci, Angelo; Marcheselli, Luigi; Pavesi, Silvia; Facchinetti, Fabio; Cascinu, Stefano; Cortesi, Laura | |
| Genomic alterations at the basis of treatment resistance in metastatic breast cancer: Clinical applications | 1-gen-2018 | Toss, Angela; Piacentini, Federico; Cortesi, Laura; Artuso, Lucia; Bernardis, Isabella; Parenti, Sandra; Tenedini, Elena; Ficarra, Guido; Maiorana, Antonino; Iannone, Anna; Omarini, Claudia; Moscetti, Luca; Cristofanilli, Massimo; Federico, Massimo; Tagliafico, Enrico | |
| Clinical and molecular predictors of long-term response in HER2 positive metastatic breast cancer patients. | 1-gen-2018 | Omarini, C; Bettelli, S; Caprera, C; Manfredini, S; Caggia, F; Guaitoli, G; Moscetti, L; Toss, A; Cortesi, L; Kaleci, S; Maiorana, A; Cascinu, S; Conte, Pf; Piacentini, F | |
| PARP inhibitors for the treatment of ovarian cancer | 1-gen-2018 | Cortesi, Lisa; Toss, A.; Cucinotto, I. | |
| First-line treatment for endocrine sensitive bone-only metastatic breast cancer: Is more always better? | 1-gen-2018 | Toss, A.; Venturelli, Marta; Sperduti, I.; Isca, Chrystel; Barbieri, Elena; Piacentini, F.; Omarini, C.; Cortesi, L.; Cascinu, S.; Moscetti, L. | |
| Clinical-Pathological Characteristics of HER2+ Breast Cancers patients among BRCA1/2+ carriers tested in Modena Cancer Center. | 1-gen-2019 | Barbolini, M; Omarini, C; Viola, L; Isca, C; Marchi, I; Caggia, F; Barbieri, E; Toss, A; Cortesi, L; Dominici, M; Piacentini, F. | |
| Endocrine therapy alone versus targeted combination strategy as first line treatment in elderly patients with hormone receptor-positive advanced breast cancer: Meta-analysis of phase II and III randomized clinical trial | 1-gen-2019 | Omarini, C; Sperduti, I; Barbolini, M; Isca, C; Bocconi, Alessandro; Toss, A; Cortesi, L; Barbieri, E; Piacentini, F; Cascinu, S; Moscetti, L | |
| BRCA mutations among triple negative breast cancer without family history of breast and ovarian cancer: The Modena family cancer clinic experience | 1-gen-2019 | Molinaro, E.; Venturelli, M.; Toss, A.; Piombino, C.; Barbieri, E.; Marcheselli, L.; Marchi, I.; Tagliafico, E.; Cascinu, S.; Cortesi, L. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile